1. SNHG1 promotes malignant biological behaviors of glioma cells via microRNA-154-5p/miR-376b-3p- FOXP2- KDM5B participating positive feedback loop
   Han Li et al, 2019, Journal of Experimental & Clinical Cancer Research CrossRef
2. Drawing a line between histone demethylase KDM5A and KDM5B: their roles in development and tumorigenesis
   Jung Yoo et al, 2022, Experimental & Molecular Medicine CrossRef
3. Transforming growth factor beta (TGF-β) activity in immuno-oncology studies
   Gabriel Gallo-Oller et al, 2020, Tumor Immunology and Immunotherapy – Integrated Methods Part B CrossRef
4. Metformin-induced chemosensitization to cisplatin depends on P53 status and is inhibited by Jarid1b overexpression in non-small cell lung cancer cells
   Tharcisio Citrangulo Tortelli et al, 2021, Aging CrossRef
5. KDM5B predicts temozolomide-resistant subclones in glioblastoma
   Vivien Ullrich et al, 2024, iScience CrossRef
6. Lysine demethylase 5B (KDM5B): A potential anti-cancer drug target
   Yi-Chao Zheng et al, 2019, European Journal of Medicinal Chemistry CrossRef
7. KDM5A and KDM5B histone-demethylases contribute to HU-induced replication stress response and tolerance
   Solenne Gaillard et al, 2021, Biology Open CrossRef
8. Potential new targets and drugs related to histone modifications in glioma treatment
   Xiuhong Wei et al, 2021, Bioorganic Chemistry CrossRef
9. Prognostic significance of RBP2-H1 variant of JARID1B in melanoma
   Łukasz Kuźbicki et al, 2017, BMC Cancer CrossRef
10. Diverse Functions of KDM5 in Cancer: Transcriptional Repressor or Activator?
    Yasuyo Ohguchi et al, 2022, Cancers CrossRef
11. KDM5 Lysine Demethylases in Pathogenesis, from Basic Science Discovery to the Clinic
    Shang-Min Zhang et al, 2023, Targeting Lysine Demethylases in Cancer and Other Human Diseases CrossRef
12. Dynamic regulation of epigenetic demethylation by oxygen availability and cellular redox
    Nermina Lamadema et al, 2019, Free Radical Biology and Medicine CrossRef